Regenerative medicine company Organogenesis Holdings Inc. is making strides in the advanced wound care, surgical and sports medicine markets in the United States with its innovative product offerings. The company's advanced wound care products, such as Affinity and Novachor, preserve cells growth factors/cytokines, and ECM proteins in native tissue. Other products include Apligraf, Dermagraft, NuShield, PuraPly, FortiShield, FiberOS and OCMP. Its pipeline products include PuraPly AM, PuraPly XT, PuraPly MZ, PuraForce and TransCyte, catering to a range of wound types. Organogenesis serves various healthcare facilities through its networks of sales representatives and independent agencies. The company, founded in 1985, is headquartered in Canton, Massachusetts.
Organogenesis's ticker is ORGO
The company's shares trade on the NASDAQ stock exchange
They are based in Canton, Massachusetts
There are 501-1000 employees working at Organogenesis
It is organogenesis.com
Organogenesis is in the Healthcare sector
Organogenesis is in the Drug Manufacturers - Other industry
The following five companies are Organogenesis's industry peers: